webleads-tracker

Home  > MEDTECH
  > MEDTECH
 
  >  TOP STORY
Once the transaction is completed, Medtronic will have significantly advanced its position as the world's premier medical technology and services company.  The combined company will have a comprehensive product portfolio, a diversified growth profile and broad geographic reach, with 87,000 ...


 
  >  ANALYSIS
10 companies that benefitted from COWIN’s support in the definition and implementation of their growth strategy presented their strategic positioning and development plan to 15 pan-European private investors, all members of COWIN’s network. These 15 venture capitalists represent more than 3B€ in managed funds. More than 80 one-on-one meetings took place during...


 
  >  PRESENTATION
Feel free to download Benjamin Roussel's presentation held at LOAC 2014 ... ...

 
  >  TRADE SHOWS & CONFERENCES
Bringing together researchers and industry participants from both academia and industry, this conference will discuss the innovative developments in Lab-on-a-Chip (LOAC), Microfluidics, and Microarrays Spaces. Presentations will explore the latest advances in LOAC, Microfluidics and Microarrays. Focus at this conference will also be given to some of the many applications of Lab-on-a-Chip, from ...
 
 
  >  LATEST REPORT
What strategies could new players use to enter the Point of Care market?...

 
  >  NEWS

Described in a paper published online July 13 in Nature Medicine, the test employs ...

Innovative technology offers potential to transform eye care and further ...

It meets the needs of microfluidic applications that benefit from an advanced ...

PerkinElmer, Inc., a global leader focused on the health and safety of people and the ...

The hunt for a perfect contraceptive has gone on for millennia. A new candidate is now ...

In a move to accelerate the transformation of the healthcare industry, Royal Philips ...

Cepheid announced a new collaboration with AstraZeneca, Cubist Pharmaceuticals, Inc., ...

The alliance will initially focus on two key priorities: the development of drug-device...

Alere Inc. (NYSE: ALR), a leading global provider of point-of-care rapid diagnostic and...

Biocartis and Abbott announced a collaboration to develop and commercialize companion ...

Once the transaction is completed, Medtronic will have significantly advanced its ...

The system offers 24 independent bioreactors in a cost effective microtiter plate ...

The company submitted the concept of a low-cost bench-top molecular biology ...

Vital Connect, an industry pioneer of wearable biosensor technology, announced today ...


©2007 Yole Developpement All rights reserved                  Disclaimer | Legal notice | To advertise
Yole Développement: Le Quartz, 75 cours Emile Zola, 69100 Villeurbanne, France. TEL: (33) 472 83 01 80 FAX: (33) 472 83 01 83 E-Mail: info @yole.fr